News
Antares Pharma Announces Next Generation of Auto-Injector Design
Antares Pharma, Inc., a leader in self-injection drug delivery technology, announced the latest advancement in its proprietary line of VIBEX(TM) auto-injectors. Antares'...
News
Pfizer Announces Positive Phase 3 Trial Results for Axitinib
Pfizer Inc.announced that the Phase 3 AXIS 1032 trial (A4061032), studying the investigational compound axitinib in previously treated patients with metastatic renal cell carcinoma (mRCC),...
News
Britannia innovates to provide Lifestyle Management Solutions for Diabetes
Britannia Industries Limited, one of India’s leading Food companies, has over the last 2 years demonstrated significant initiatives in the Health and Wellness space. Its...
News
Eisai Inc. Received U.S Food and Drug Administration for...
Eisai Inc. announced that the United States Food and Drug Administration (FDA) has approved Halavenâ„¢ (eribulin mesylate) Injection for the treatment of patients with metastatic...
News
MorphoSys Launches New Antibody Technology
MorphoSys AG has launched a novel antibody optimization platform called arYla. The company plans to use arYla to accelerate antibody optimization, with the goal of...
News
Biomoda Selects Quintiles To Refine Lung Cancer Tests
Biomoda, Inc. has allied with Quintiles Global Central Laboratories to help refine the automated image recognition system for measuring the photon emission rate and cell...
News
Boehringer Ingelheim entered into a collabration agreement with VTU...
Boehringer Ingelheim, a global leader in biopharmaceutical contract development and manufacture, and VTU Technology, a leading supplier of exclusive technologies and comprehensive services for the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.